Eligibility for omalizumab dosing in children and young adults based on IgE and body weight

Category Primary study
JournalJournal of Allergy and Clinical Immunology
Year 2009
This article has no abstract
Epistemonikos ID: 1eb47c489f35cd4057cfc251c756653c5294c1a2
First added on: Feb 28, 2025